SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-16-018408
Filing Date
2016-09-23
Accepted
2016-09-23 16:10:35
Documents
3
Effectiveness Date
2016-09-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS t1602292_defa14a.htm DEFA14A 25020
2 GRAPHIC logo.jpg GRAPHIC 37422
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 19312
  Complete submission text file 0001571049-16-018408.txt   104630
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 161899929
SIC: 2834 Pharmaceutical Preparations